Medtech InsightWhen conservative methods for addressing joint pain are no longer an option, joint replacement may be the solution. The rising aging population and increasing prevalence of chronic diseases like obesi
ScripRanbaxy Laboratorieshas signed an exclusive licensing agreement with BioPro Pharmaceutical of the US to promote and market Gliadel Wafer (polifeprosan 20 with carmustine implant) in India. The US FDA-